Clinical trial
Magnetic Seizure Therapy (MST) for the Treatment of Major Depression
NCT00973934 is registered in ClinicalTrials.gov with Sarah Lisanby as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Magnetic Seizure Therapy (MST) for the Treatment of Major Depression
- Lead sponsor
- Sarah Lisanby
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 30, 2002
- Completion date
- December 31, 2009
- Enrollment
- 20 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.